Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2013

01-06-2013 | Endocrine Tumors

Technical and Oncologic Safety of Robotic Thyroid Surgery

Authors: Onvox Yi, MD, Jong Ho Yoon, MD, PhD, Yu-Mi Lee, MD, Tae-Yon Sung, MD, PhD, Ki-Wook Chung, MD, PhD, Tae Yong Kim, MD, PhD, Won Bae Kim, MD, PhD, Young Kee Shong, MD, PhD, Jin-Sook Ryu, MD, PhD, Suck Joon Hong, MD, PhD

Published in: Annals of Surgical Oncology | Issue 6/2013

Login to get access

Abstract

Background

The aim of this study was to evaluate the surgical outcomes of a double-incision robot-assisted gasless transaxillary thyroidectomy procedure compared with conventional open thyroid surgery.

Methods

We enrolled and analyzed 521 female patients with classic papillary thyroid carcinoma (PTC) who underwent a total thyroidectomy with central compartment node dissection (CCND) at the Asan Medical Center in Seoul, Korea from December 2008 to December 2010. These patients were classified into robotic (N = 98) or open (N = 423) groups and were compared with respect to clinicopathologic characteristics, complications, and stimulated thyroglobulin (sTg) levels at the time of immediate postoperative radioactive iodine remnant ablation (ablation sTg) and at 6–12 months after the first ablation (control sTg).

Results

The rate of perioperative complications was also similar, except for transient hypoparathyroidism in the robotic group. The median ablation sTg levels (0.39 vs 0.50 ng/mL, P = 0.215) and the proportion of patients with ablation sTg levels <10 ng/mL (94.5 vs 98.0 %, P = 0.103) were also comparable between the robotic and open groups. In addition, the proportion of patients with control sTg levels <1 ng/mL in both robotic and open groups (91.3 vs 95.6 %, P = 0.079) did not show a significant difference.

Conclusions

Robotic thyroid surgery using a double-incision gasless transaxillary approach is technically safe and may provide a feasible option for a complete thyroid resection and adequate lymph node dissection in patients with PTC.
Literature
1.
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295:2164–7.PubMedCrossRef
2.
Lee KE, Koo do H, Im HJ, Park SK, Choi JY, Paeng JC, et al. Surgical completeness of bilateral axillo-breast approach robotic thyroidectomy: comparison with conventional open thyroidectomy after propensity score matching. Surgery. 2011;150:1266–74.PubMedCrossRef
3.
4.
Bae JS, Cho YU, Sung GY, Oh SJ, Jung EJ, Lee JB, et al. The current status of endoscopic thyroidectomy in Korea. Surg Laparosc Endosc Percutan Tech. 2008;18:231–5.PubMedCrossRef
5.
Lee S, Ryu HR, Park JH, Kim KH, Kang SW, Jeong JJ, et al. Early surgical outcomes comparison between robotic and conventional open thyroid surgery for papillary thyroid microcarcinoma. Surgery. 2012;151:724–30.PubMedCrossRef
6.
Kandil EH, Noureldine SI, Yao L, Slakey DP. Robotic transaxillary thyroidectomy: an examination of the first one hundred cases. J Am Coll Surg. 2012;214:558–64; discussion 64–6.
7.
Kandil E, Abdelghani S, Noureldine SI, Friedlander P, Abdel Khalek M, Bellows CF, et al. Transaxillary gasless robotic thyroidectomy: a single surgeon’s experience in North America. Arch Otolaryngol Head Neck Surg. 2012;138:113–7.PubMedCrossRef
8.
Yoo H, Chae BJ, Park HS, Kim KH, Kim SH, Song BJ, et al. Comparison of surgical outcomes between endoscopic and robotic thyroidectomy. J Surg Oncol. 2012;105:705–8.PubMedCrossRef
9.
Tae K, Ji YB, Jeong JH, Lee SH, Jeong MA, Park CW. Robotic thyroidectomy by a gasless unilateral axillo-breast or axillary approach: our early experiences. Surg Endosc. 2011;25:221–8.PubMedCrossRef
10.
Tae K, Ji YB, Cho SH, Lee SH, Kim DS, Kim TW. Early surgical outcomes of robotic thyroidectomy by a gasless unilateral axillo-breast or axillary approach for papillary thyroid carcinoma: 2 years’ experience. Head Neck. 2012;34:617–25.PubMedCrossRef
11.
Kim WW, Kim JS, Hur SM, Kim SH, Lee SK, Choi JH, et al. Is robotic surgery superior to endoscopic and open surgeries in thyroid cancer? World J Surg. 2011;35:779–84.PubMedCrossRef
12.
Lee J, Lee JH, Nah KY, Soh EY, Chung WY. Comparison of endoscopic and robotic thyroidectomy. Ann Surg Oncol. 2011;18:1439–46.PubMedCrossRef
13.
Lee J, Kang SW, Jung JJ, Choi UJ, Yun JH, Nam KH, et al. Multicenter study of robotic thyroidectomy: short-term postoperative outcomes and surgeon ergonomic considerations. Ann Surg Oncol. 2011;18:2538–47.PubMedCrossRef
14.
Kang SW, Park JH, Jeong JS, Lee CR, Park S, Lee SH, et al. Prospects of robotic thyroidectomy using a gasless, transaxillary approach for the management of thyroid carcinoma. Surg Laparosc Endosc Percutan Tech. 2011;21:223–9.PubMedCrossRef
15.
Kuppersmith RB, Holsinger FC. Robotic thyroid surgery: an initial experience with North American patients. Laryngoscope. 2011;121:521–6.PubMedCrossRef
16.
Lee KE, Koo do H, Kim SJ, Lee J, Park KS, Oh SK, et al. Outcomes of 109 patients with papillary thyroid carcinoma who underwent robotic total thyroidectomy with central node dissection via the bilateral axillo-breast approach. Surgery. 2010;148:1207–13.
17.
Lee J, Nah KY, Kim RM, Ahn YH, Soh EY, Chung WY. Differences in postoperative outcomes, function, and cosmesis: open versus robotic thyroidectomy. Surg Endosc. 2010;24:3186–94.PubMedCrossRef
18.
Kang SW, Lee SH, Ryu HR, Lee KY, Jeong JJ, Nam KH, et al. Initial experience with robot-assisted modified radical neck dissection for the management of thyroid carcinoma with lateral neck node metastasis. Surgery. 2010;148:1214–21.PubMedCrossRef
19.
Jeong JJ, Kang SW, Yun JS, Sung TY, Lee SC, Lee YS, et al. Comparative study of endoscopic thyroidectomy versus conventional open thyroidectomy in papillary thyroid microcarcinoma (PTMC) patients. J Surg Oncol. 2009;100:477–80.PubMedCrossRef
20.
Kang SW, Jeong JJ, Nam KH, Chang HS, Chung WY, Park CS. Robot-assisted endoscopic thyroidectomy for thyroid malignancies using a gasless transaxillary approach. J Am Coll Surg. 2009;209:e1–7.PubMedCrossRef
21.
Kang SW, Jeong JJ, Yun JS, Sung TY, Lee SC, Lee YS, et al. Robot-assisted endoscopic surgery for thyroid cancer: experience with the first 100 patients. Surg Endosc. 2009;23:2399–406.PubMedCrossRef
22.
Han JM, Kim WB, Yim JH, Kim WG, Kim TY, Ryu JS, et al. The long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level at one year after initial treatment. Thyroid. 2012;22:784–90.
23.
Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med. 2012;366:1663–73.PubMedCrossRef
24.
Kim EY, Kim TY, Kim WG, Yim JH, Han JM, Ryu JS, et al. Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma. Nucl Med Commun. 2011;32:954–9.PubMedCrossRef
25.
Webb RC, Howard RS, Stojadinovic A, Gaitonde DY, Wallace MK, Ahmed J, et al. The utility of serum thyroglobulin measurement at the time of remnant ablation for predicting disease-free status in patients with differentiated thyroid cancer: a meta-analysis involving 3,947 patients. J Clin Endocrinol Metab. 2012;97:2754–63.PubMedCrossRef
26.
Kim TY, Kim WB, Kim ES, Ryu JS, Yeo JS, Kim SC, et al. Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2005;90:1440–5.PubMedCrossRef
Metadata
Title
Technical and Oncologic Safety of Robotic Thyroid Surgery
Authors
Onvox Yi, MD
Jong Ho Yoon, MD, PhD
Yu-Mi Lee, MD
Tae-Yon Sung, MD, PhD
Ki-Wook Chung, MD, PhD
Tae Yong Kim, MD, PhD
Won Bae Kim, MD, PhD
Young Kee Shong, MD, PhD
Jin-Sook Ryu, MD, PhD
Suck Joon Hong, MD, PhD
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 6/2013
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2850-0

Other articles of this Issue 6/2013

Annals of Surgical Oncology 6/2013 Go to the issue

Thoracic Oncology

Repeated Resection of Colorectal Cancer Pulmonary Oligometastases: Pooled Analysis and Prognostic Assessment

Thoracic Oncology

Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery

Gynecologic Oncology

A Prospective Validation Study to Diagnose Serosal Invasion and Nodal Metastases of Gastric Cancer by Multidetector-row CT

Bone and Soft Tissue Sarcomas

Predictors of Survival and Recurrence in Primary Leiomyosarcoma

Thoracic Oncology

Predictive Factors of Lymph Node Status in Small Peripheral Non-small Cell Lung Cancers: Tumor Histology is More Reliable

Melanomas

How Often do Level III Nodes Bear Melanoma Metastases and does it Affect Patient Outcomes?